Identification of β2-microglobulin as a urinary biomarker for chronic allograft nephropathy using proteomic methods.
Maguire, Patricia B
Ryan, Michael P
Conlon, Peter J
AffiliationSchool of Biomolecular and Biomedical Science, Conway Institute, University College Dublin, Belfield, Dublin, Ireland.
Glomerulosclerosis, Focal Segmental
Protein Array Analysis
Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization
MetadataShow full item record
CitationIdentification of β2-microglobulin as a urinary biomarker for chronic allograft nephropathy using proteomic methods. 2011, 5 (7-8):422-31 Proteomics Clin Appl
JournalProteomics. Clinical applications
AbstractChronic allograft nephropathy (CAN) remains the leading cause of renal graft loss after the first year following renal transplantation. This study aimed to identify novel urinary proteomic profiles, which could distinguish and predict CAN in susceptible individuals.
- Urinary beta2-microglobulin is associated with acute renal allograft rejection.
- Authors: Oetting WS, Rogers TB, Krick TP, Matas AJ, Ibrahim HN
- Issue date: 2006 May
- Application of serum SELDI proteomic patterns in diagnosis of lung cancer.
- Authors: Yang SY, Xiao XY, Zhang WG, Zhang LJ, Zhang W, Zhou B, Chen G, He DC
- Issue date: 2005 Jul 20
- A serum proteomic pattern for the detection of colorectal adenocarcinoma using surface enhanced laser desorption and ionization mass spectrometry.
- Authors: Liu XP, Shen J, Li ZF, Yan L, Gu J
- Issue date: 2006 Dec
- Identification of lung cancer patients by serum protein profiling using surface-enhanced laser desorption/ionization time-of-flight mass spectrometry.
- Authors: Han KQ, Huang G, Gao CF, Wang XL, Ma B, Sun LQ, Wei ZJ
- Issue date: 2008 Apr
- Identification of protein biomarkers in Dupuytren's contracture using surface enhanced laser desorption ionization time-of-flight mass spectrometry (SELDI-TOF-MS).
- Authors: O'Gorman D, Howard JC, Varallo VM, Cadieux P, Bowley E, McLean K, Pak BJ, Gan BS
- Issue date: 2006 Jun